Literature DB >> 1605195

Three families with high expression of a fragile site at Xq27.3, lack of anomalies at the FMR-1 CpG island, and no clear phenotypic association.

I Oberlé1, J Boué, M F Croquette, M A Voelckel, M G Mattei, J L Mandel.   

Abstract

We report on 3 families where the presence and segregation at high frequency of a fragile Xq27.3 site is not associated with the mutations and methylation anomalies typically seen in the fragile X [Fra(X)] syndrome. In one family, a folate insensitive fragile site was associated with Robin sequence in the propositus. In a second family a fra(X) negative mother has two fra(X) positive sons (one mentally retarded and the other newborn). The third family presents very high expression of a folate sensitive site, unlinked to mental retardation, and was described previously by Voelckel et al. [1989]. The fragile sites in these or similar families recently described must be different from the one associated with the fra(X) syndrome. Their association with a clinical phenotype or with mental retardation is certainly not consistent, and may represent an ascertainment bias. However, the relatively high frequency with which they have been found among previously diagnosed fra(X) families suggests that, at least in some cases, the association with mental impairment may be significant. In two families reported up to now, a male with high expression of such variant fra(X) site failed to transmit it to his daughter, which may reflect an imprinting effect. Previously diagnosed families should be reinvestigated before direct DNA analysis is used for prenatal or carrier diagnosis of the fra(X) syndrome.

Entities:  

Mesh:

Year:  1992        PMID: 1605195     DOI: 10.1002/ajmg.1320430136

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  4 in total

1.  Identification of the FRAXE fragile site in two families ascertained for X linked mental retardation.

Authors:  G A Flynn; M C Hirst; S J Knight; J N Macpherson; J C Barber; A V Flannery; K E Davies; V J Buckle
Journal:  J Med Genet       Date:  1993-02       Impact factor: 6.318

2.  Segregation of FRAXE in a large family: clinical, psychometric, cytogenetic, and molecular data.

Authors:  B C Hamel; A P Smits; E de Graaff; D F Smeets; F Schoute; B H Eussen; S J Knight; K E Davies; C F Assman-Hulsmans; B A Oostra
Journal:  Am J Hum Genet       Date:  1994-11       Impact factor: 11.025

3.  Expansion and methylation status at FRAXE can be detected on EcoRI blots used for FRAXA diagnosis: analysis of four FRAXE families with mild mental retardation in males.

Authors:  V Biancalana; L Taine; J C Bouix; S Finck; A Chauvin; H De Verneuil; S J Knight; C Stoll; D Lacombe; J L Mandel
Journal:  Am J Hum Genet       Date:  1996-10       Impact factor: 11.025

4.  Analysis of a CGG sequence at the FMR-1 locus in fragile X families and in the general population.

Authors:  K Snow; L K Doud; R Hagerman; R G Pergolizzi; S H Erster; S N Thibodeau
Journal:  Am J Hum Genet       Date:  1993-12       Impact factor: 11.025

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.